attachment

Give me answer short

Reading File
Finding Sources
Here are the answers for the clinical pharmacology practical exam:

Case 14: 37-year-old male, after ceftriaxone administration → lip/eye/tongue swelling, itching, skin redness, difficulty breathing, BP 90/60, HR 100/min.

Station 1 — Diagnosis

Anaphylaxis (severe type I hypersensitivity / IgE-mediated allergic reaction to ceftriaxone)

Station 2 — P-Medication Choice: Epinephrine (Adrenaline)

3. Dosage Form

Injection solution (1:1000 = 1 mg/mL)

4. Dosage

0.3–0.5 mg IM (intramuscular, anterolateral thigh); repeat every 5–15 min if needed

Station 3

5. Pharmacokinetics

  • Absorption: Rapid after IM injection
  • Distribution: Wide; crosses blood-brain barrier poorly
  • Metabolism: Rapidly metabolized by MAO and COMT in liver/tissues
  • Elimination: Renal excretion of metabolites; short half-life (~2 min)

6. Mechanism of Action

Epinephrine is a non-selective adrenergic agonist (α1, α2, β1, β2):
  • α1: Vasoconstriction → raises BP, reduces mucosal edema
  • β1: Increases heart rate and cardiac output
  • β2: Bronchodilation, suppresses further mediator release from mast cells

7. Prescription

Epinephrine 1 mg/mL (1:1000) injection
Dose: 0.5 mg IM into anterolateral thigh
Repeat once after 5–15 min if no improvement

8. Duration of Treatment

Single/repeated acute doses until stabilized; observe patient for at least 4–6 hours (risk of biphasic anaphylaxis)

9. Side Effects

  • Tachycardia, palpitations, hypertension
  • Anxiety, tremor, headache
  • Pallor, sweating
  • Hyperglycemia

10. Contraindications

No absolute contraindications in anaphylaxis (benefit always outweighs risk). Relative: Severe hypertension, coronary artery disease, hyperthyroidism — use with caution but do NOT withhold in true anaphylaxis.
This is a shared conversation. Sign in to Orris to start your own chat.